Vascular Biogenics Ltd (VBLT)

[Valueinvestor12]

Pay attention to the answer ' unexpected, happening" below under Dror Harats answer to the question at the end of the second line.

Dr. Dror always said the end of the year but now he is attaching unexpected, happening to his answer. I think just my opinion something might happen before the end of the year like a buy out or partnership and vblt will not have to do phase 3 ovarian cancer.

Charles Duncan

Just two quick ones in terms of beyond its initial indication for VB-111 in ovarian cancer. Dror, have you made progress towards starting that trial? And could you help us understand that progress?

Dror Harats

Yes, we did actually make progress. And we are going to start the trial, as we said, before the end of this year, unless something which is unexpected, happening. We already got to an agreement with CRO, which is mainly a public CRO, that dealing with ovarian and it's actually an expert type of CRO. And we will announce it when it's ready. And we felt that the right announcement should come when we have the first patient in but that’s going to happen soon. All the rest is basically already agreed with FDA with some of the regulatory authorities we already got a green light. We are actually had a kick-off meeting for the trial, we are getting done.